Validation of the 8th edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy

Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing

(2018) I H Nauta et al.   ANNALS OF ONCOLOGY

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

(2018) Hisham Mehanna et al.   LANCET

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

(2018) Maura L Gillison et al.   LANCET

Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan

(2017) Takatsugu Mizumachi et al.   International Journal of Clinical Oncology

Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy

(2017) Sandro V Porceddu et al.   ORAL ONCOLOGY

Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma

(2017) Nora Würdemann et al.   Frontiers in Oncology

Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study

(2016) Emilie Garnaes et al.   INTERNATIONAL JOURNAL OF CANCER

Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study

(2016) Brian O'Sullivan et al.   LANCET ONCOLOGY

Refining American Joint Committee on Cancer/Union for International Cancer Control TNM Stage and Prognostic Groups for Human Papillomavirus–Related Oropharyngeal Carcinomas

(2015) Shao Hui Huang et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved survival using intensity-modulated radiation therapy in head and neck cancers: A SEER-Medicare analysis

(2014) Beth M. Beadle et al.   CANCER

Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas

(2013) Michelle M. Rietbergen et al.   INTERNATIONAL JOURNAL OF CANCER

Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis

(2013) Brian O'Sullivan et al.   JOURNAL OF CLINICAL ONCOLOGY

Intensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: Outcomes from a single-institution series

(2013) Meredith Johnston et al.   Journal of Medical Imaging and Radiation Oncology

An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center

(2012) Kristina R. Dahlstrom et al.   CANCER

Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis

(2011) Tejpal Gupta et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

(2010) K. Kian Ang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22)

(2009) Avraham Eisbruch et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS